Kanavos P - Search Results

1

The role of funding and policies on innovation in cancer drug development.

Kanavos P, Sullivan R, Lewison G, Schurer W, Eckhouse S, Vlachopioti Z. Kanavos P, et al. Ecancermedicalscience. 2010;4:164. doi: 10.3332/ecancer.2010.164. Epub 2010 Feb 3. Ecancermedicalscience. 2010. PMID: 22276026 Free PMC article. No abstract available.

2

Colorectal cancer management in the United Kingdom: current practice and challenges.

Schurer W, Kanavos P. Schurer W, et al. Among authors: kanavos p. Eur J Health Econ. 2010 Jan;10 Suppl 1:S85-90. doi: 10.1007/s10198-009-0202-1. Eur J Health Econ. 2010. PMID: 20012128

3

The dynamics of colorectal cancer management in 17 countries.

Kanavos P, Schurer W. Kanavos P, et al. Eur J Health Econ. 2010 Jan;10 Suppl 1:S115-29. doi: 10.1007/s10198-009-0201-2. Eur J Health Econ. 2010. PMID: 20012129

4

The burden of colorectal cancer: prevention, treatment and quality of services.

Kanavos P, Schurer W. Kanavos P, et al. Eur J Health Econ. 2010 Jan;10 Suppl 1:S1-3. doi: 10.1007/s10198-009-0200-3. Eur J Health Econ. 2010. PMID: 20012130 No abstract available.

5

Mapping research activity on mental health disorders in Europe: study protocol for the Mapping_NCD project.

Berg Brigham K, Darlington M, Wright JS, Lewison G, Kanavos P, Durand-Zaleski I; Mapping_NCD consortium. Berg Brigham K, et al. Among authors: kanavos p. Health Res Policy Syst. 2016 May 26;14(1):39. doi: 10.1186/s12961-016-0111-6. Health Res Policy Syst. 2016. PMID: 27230585 Free PMC article.

6

What is wrong with orphan drug policies? Suggestions for ways forward.

Kanavos P, Nicod E. Kanavos P, et al. Value Health. 2012 Dec;15(8):1182-4. doi: 10.1016/j.jval.2012.08.2202. Epub 2012 Oct 25. Value Health. 2012. PMID: 23244822 Free article.

7

The rising burden of cancer in the developing world.

Kanavos P. Kanavos P. Ann Oncol. 2006 Jun;17 Suppl 8:viii15-viii23. doi: 10.1093/annonc/mdl983. Ann Oncol. 2006. PMID: 16801335 Free article. Review.

8

Prescription drug coverage among elderly and disabled Americans: can Medicare-Part D reduce inequities in access?

Kanavos P, Gemmill-Toyama M. Kanavos P, et al. Int J Health Care Finance Econ. 2010 Sep;10(3):203-18. doi: 10.1007/s10754-010-9077-z. Epub 2010 Mar 6. Int J Health Care Finance Econ. 2010. PMID: 20213234

9

The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors.

von der Schulenburg F, Vandoros S, Kanavos P. von der Schulenburg F, et al. Among authors: kanavos p. Health Econ Rev. 2011 Nov 21;1(1):18. doi: 10.1186/2191-1991-1-18. Health Econ Rev. 2011. PMID: 22828053 Free PMC article.

10

Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs.

Kanavos P, Ferrario A, Vandoros S, Anderson GF. Kanavos P, et al. Health Aff (Millwood). 2013 Apr;32(4):753-61. doi: 10.1377/hlthaff.2012.0920. Health Aff (Millwood). 2013. PMID: 23569056

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters